It is not intended to diagnose, treat, cure, or prevent any medical condition
Other GLP-1 Analogs: Short-Acting vs Long-Acting After exenatide and liraglutide, several other GLP-1 receptor agonists were introduced in the early-to-mid 2010s
doi: 10.3389/fphar.2020.00473 142 TomasiI
These lawsuits allege that the drugs were causing severe side effects such as gastrointestinal injuries, stomach paralysis, and intestinal blockages, that were not adequately warned about on the drug labels and also claim that the drugs safety is questionable due to lack of safety studies over an extended period of time
however, robust protection against severe disease has been maintained
Plus, try on one of the five looks on display in the store Fresh, Sunny, Chic, Daring, and Glam by simply stepping in front of an iPad